U-Ploid Biotechnologies Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1.25M

  • Investors
  • 4

U-Ploid Biotechnologies General Information

Description

Developer of a biopharmaceutical platform intended to address chromosomal errors in human oocytes to improve fertility outcomes. The company offers engineered fusion protein therapeutics targeting egg maturation processes, enabling individuals undergoing fertility treatment, to improve success rates and reproductive potential.

Contact Information

Website
www.u-ploid.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 696, Innovation Building
  • Bioescalator Old Road Campus, Roosevelt Drive, Headington
  • Oxford OX3 7FZ
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Building 696, Innovation Building
  • Bioescalator Old Road Campus, Roosevelt Drive, Headington
  • Oxford OX3 7FZ
  • England, United Kingdom

U-Ploid Biotechnologies Timeline

20252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

U-Ploid Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 19-May-2026 $1.25M Completed Pre-Clinical Trials
3. Seed Round 23-Apr-2025 Completed Pre-Clinical Trials
2. Early Stage VC (Series 1) 22-Jul-2024 $1.5M $1.51M Completed Pre-Clinical Trials
1. Accelerator/Incubator 29-May-2024 $12.6K $12.6K Completed Startup
To view U-Ploid Biotechnologies’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

U-Ploid Biotechnologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biopharmaceutical platform intended to address chromosomal errors in human oocytes to improve fertility o
Biotechnology
Oxford, United Kingdom
8 As of 2026

Austin, TX
 

Berkeley, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

U-Ploid Biotechnologies Competitors (3)

One of U-Ploid Biotechnologies’s 3 competitors is Gameto, a Venture Capital-Backed company based in Austin, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gameto Venture Capital-Backed Austin, TX
Conception Venture Capital-Backed Berkeley, CA
Conceivable Life Sciences Venture Capital-Backed New York, NY
You’re viewing 3 of 3 competitors. Get the full list »

U-Ploid Biotechnologies Patents

U-Ploid Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202413656-D0 Methods and compositions Inactive 17-Sep-2024
WO-2026062373-A2 Methods and compositions Pending 17-Sep-2024
WO-2026062373-A3 Methods and compositions Pending 17-Sep-2024 C12N9/6472

U-Ploid Biotechnologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

U-Ploid Biotechnologies Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Avonmore Developments Venture Capital Minority
Blue Collective Venture Capital Minority
Wilbe Capital Venture Capital Minority
Accelerate@Babraham Accelerator/Incubator Minority
To view U-Ploid Biotechnologies’s complete investors history, request access »

U-Ploid Biotechnologies FAQs

  • When was U-Ploid Biotechnologies founded?

    U-Ploid Biotechnologies was founded in 2024.

  • Where is U-Ploid Biotechnologies headquartered?

    U-Ploid Biotechnologies is headquartered in Oxford, United Kingdom.

  • What is the size of U-Ploid Biotechnologies?

    U-Ploid Biotechnologies has 8 total employees.

  • What industry is U-Ploid Biotechnologies in?

    U-Ploid Biotechnologies’s primary industry is Biotechnology.

  • Is U-Ploid Biotechnologies a private or public company?

    U-Ploid Biotechnologies is a Private company.

  • What is the current valuation of U-Ploid Biotechnologies?

    The current valuation of U-Ploid Biotechnologies is .

  • What is U-Ploid Biotechnologies’s current revenue?

    The current revenue for U-Ploid Biotechnologies is .

  • How much funding has U-Ploid Biotechnologies raised over time?

    U-Ploid Biotechnologies has raised $3.76M.

  • Who are U-Ploid Biotechnologies’s investors?

    Avonmore Developments, Blue Collective, Wilbe Capital, and Accelerate@Babraham have invested in U-Ploid Biotechnologies.

  • Who are U-Ploid Biotechnologies’s competitors?

    Gameto, Conception, and Conceivable Life Sciences are competitors of U-Ploid Biotechnologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process